Primary Progesterone Therapy for Operable Breast Cancer
NCT00123669
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
1000
Enrollment
OTHER_GOV
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
500 mg of depot hydroxy-progesterone
Sponsor
Tata Memorial Hospital
Collaborators
[object Object]